GBM150 GBM Model

GBM150 PDX model is a fundamental asset in preclinical Brain Cancer drug discovery, offering essential insights for treatment development. Its ability to faithfully replicate patient responses empowers researchers to tailor therapies to individual patient needs, advancing the quest for safer and more effective Brain Cancer treatments. By serving as a reliable representation of patient outcomes, GBM150 PDX plays a pivotal role in accelerating the translation of discoveries from the laboratory to clinical success.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM150
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM150 Survival

Survival of orthotopic intracranial implanted  GBM150 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content